I'd say that depressing and unrealistic, unless the whole market tanks and takes INSM with it, then $7 may be high for a while.
What are you expecting, bad news leaks on NTM?
I see a few of the traders put down the fishing pole to chime in.( I know you're out there Cindy! )) $7.23 is a 50% retrace and longtime holders know this was right where their shares got liquidated for Transave.
in the 8's , is a test of the 200 day and my initial target (998) is a 38% retracement... jad9000 posted what is obvious - the shorts are the longs.This is a very common technique after a biotech offering where Institutions just lend and look the other way - everyone makes money.
bad news or weak results allows them to cover,or the price will be low enough to still profit on excellent news.The odds favor that IF there is any news in the interim to NTM data( wedbush now says 1st qtr 2014) ,it will not be favorable, should the EU find problems , a dilution via money expenditure for an additional trial or a delay ( EU requests more data).
I think the shorts ,opps , I mean the longs know what happens next, I dont but Im a technical trader not a buffoon conjuring up scenarios that have no relevance. fud4 has never been right once- not once in 9 years.
Blah blah blah. You're so full of it. It's amazing if you think anyone takes you seriously. I laugh at every thing you say. Such bull. If the shear frequency of your posting doesn't give you away (as a paid pumping short), your poor fact-less statements and base-less claims surely do. Blah blah blah.